Merck: Navigating Patent Cliff and Growth Prospects
Merck faces the challenge of expiring patents while pushing a robust pipeline and disciplined capital moves. This gui...
Looking for the best places to invest for maximum returns in 2023? Discover effective strategies to enhance your investment portfolio.
14,465 articlesMerck faces the challenge of expiring patents while pushing a robust pipeline and disciplined capital moves. This gui...
When the market wakes up to a notable move in Smucker shares, it often signals more than a one-off beat. This article...
From 2010 to 2022, real estate investing looked like a smooth ride fueled by easy credit and rising prices. This arti...
IEFA provides broad exposure to developed markets outside the U.S. with a low fee and a 3.4% dividend yield. Today’s ...
As markets stabilize in 2026, a new approach to retirement planning promotes spending more now with a structured, ris...
Trying to choose between two popular small-cap value ETFs? This clear, readers-friendly guide breaks down costs, risk...
PTIR's double-leveraged bet on Palantir underperformed the stock by nearly half over the past year, underscoring the ...
Two very different approaches to growth: Nvidia leads AI hardware and software, while Strategy blends software with B...
Analysts publish a broad slate of Wednesday notes, highlighting opportunities across metals, energy, consumer staples...
Markets feel expensive, but Warren Buffett keeps it simple. This article explores the one low-cost investment he’s tr...
Thai and Taiwanese AI stock funds are gaining traction as Korea’s AI boom extends across Asia. This report examines w...
As Citi gears up for its 2026 earnings call, investors need a clear view of the revenue mix, credit quality, and capi...